103 related articles for article (PubMed ID: 26628458)
1. PrEP on demand cuts HIV transmission in high risk men, study finds.
McCarthy M
BMJ; 2015 Dec; 351():h6468. PubMed ID: 26628458
[No Abstract] [Full Text] [Related]
2. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
[TBL] [Abstract][Full Text] [Related]
3. TDF-FTC before and after sex reduced HIV infection but increased GI, renal events in men who have sex with men.
Maki DG
Ann Intern Med; 2016 Mar; 164(6):JC28. PubMed ID: 26974728
[No Abstract] [Full Text] [Related]
4. NHS England should reconsider PrEP decision.
The Lancet Hiv
Lancet HIV; 2016 May; 3(5):e191. PubMed ID: 27126479
[No Abstract] [Full Text] [Related]
5. PURLs: On-demand pill protocol protects against HIV.
Justesen K; Prasad S
J Fam Pract; 2016 Aug; 65(8):556-8. PubMed ID: 27660840
[TBL] [Abstract][Full Text] [Related]
6. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
7. Unsupervised PrEP in routine practice: a new challenge?
Laroche H; Lions C; Zaegel-Faucher O; Tamalet C; Poizot-Martin I
Int J STD AIDS; 2019 Jun; 30(7):715-717. PubMed ID: 30975069
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
Hoornenborg E; Prins M; Achterbergh RCA; Woittiez LR; Cornelissen M; Jurriaans S; Kootstra NA; Anderson PL; Reiss P; de Vries HJC; Prins JM; de Bree GJ;
Lancet HIV; 2017 Nov; 4(11):e522-e528. PubMed ID: 28919303
[TBL] [Abstract][Full Text] [Related]
9. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
10. HIV-1-infection in a man who has sex with men despite self-reported excellent adherence to pre-exposure prophylaxis, the Netherlands, August 2021: be alert to emtricitabine/tenofovir-resistant strain transmission.
Koole JC; de la Court F; Welkers MR; Yap K; Stalenhoef JE; Jurriaans S; de Vries HJ; Op de Coul EL; Prins M; Hoornenborg E
Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393931
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study.
Nichols BE; Boucher CAB; van der Valk M; Rijnders BJA; van de Vijver DAMC
Lancet Infect Dis; 2016 Dec; 16(12):1423-1429. PubMed ID: 27665989
[TBL] [Abstract][Full Text] [Related]
12. Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.
Chang HH; Kim SW; Jung H; Lee SA; Park HK; Kim S; Lee JM; Choi JY
J Korean Med Sci; 2018 Mar; 33(12):e91. PubMed ID: 29542300
[TBL] [Abstract][Full Text] [Related]
13. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.
Reyniers T; Hoornenborg E; Vuylsteke B; Wouters K; Laga M
Sex Transm Infect; 2017 Aug; 93(5):363-367. PubMed ID: 27872326
[TBL] [Abstract][Full Text] [Related]
14. Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation.
Landovitz RJ
Top Antivir Med; 2015; 23(2):85-90. PubMed ID: 26200708
[TBL] [Abstract][Full Text] [Related]
15. Estimating the budget impact of adopting tenofovir/emtricitabine for pre-exposure prophylaxis of HIV in the public health sector in Namibia (2021 - 2023).
Moyo E; Barham L; Mhango M; Musuka G; Dzinamarira T
J Infect Public Health; 2022 Oct; 15(10):1147-1155. PubMed ID: 36162151
[TBL] [Abstract][Full Text] [Related]
16. Changing from Tenofovir/Emtricitabine to Cabotegravir for Pre Exposure Prophylaxis for HIV in Men who have Sex with Men: A Cost Utility Analysis from an Endemic Country.
Joob B; Wiwanikit V
J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436834
[No Abstract] [Full Text] [Related]
17. Reply: Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men.
Mizushima D; Gatanaga H; Oka S
Hepatology; 2023 Nov; 78(5):E98. PubMed ID: 37560991
[No Abstract] [Full Text] [Related]
18. Letter to the Editor: Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men.
Hung CT; Hsu SJ; Liu CJ
Hepatology; 2023 Nov; 78(5):E97. PubMed ID: 37738208
[No Abstract] [Full Text] [Related]
19. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
Özdener AE; Park TE; Kalabalik J; Gupta R
Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
[TBL] [Abstract][Full Text] [Related]
20. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.
Mugo PM; Sanders EJ; Mutua G; van der Elst E; Anzala O; Barin B; Bangsberg DR; Priddy FH; Haberer JE
AIDS Behav; 2015 May; 19(5):794-801. PubMed ID: 25432877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
